Gengraf and Multivitamin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gengraf (cyclosporine) and Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include skin hypertrophy among females and blood pressure increased among males.
The phase IV clinical study analyzes what interactions people have when they take Gengraf and Multivitamin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Gengraf?
Gengraf has active ingredients of cyclosporine. eHealthMe is studying from 960 Gengraf users. Check the latest studies of Gengraf.
What is Multivitamin?
Multivitamin has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 83,597 Multivitamin users. Check the latest studies of Multivitamin.
18 people who take Gengraf and Multivitamin together, and have interactions are studied.

What are the common drug interactions of Gengraf and Multivitamin, by gender? *:
female:
- Skin hypertrophy (skin cells enlarges)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin tightness
- Soft tissue disorder (disease of soft tissue)
- Spinal compression fracture (fracture due to spinal compression on bone)
- Stress
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Tooth loss
- Upper extremity mass
- Upper limb fracture
male:
- Blood pressure increased
- Diarrhoea
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Abdominal pain
- Arthralgia (joint pain)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood creatine increased
- Blood glucose increased
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
- Depression
What are the common drug interactions of Gengraf and Multivitamin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Apathy
- Arthralgia (joint pain)
- Asthenia (weakness)
- Decreased appetite
- Fatigue (feeling of tiredness)
- Haematocrit decreased
- Hyperaesthesia
- Myalgia (muscle pain)
- Oedema peripheral (superficial swelling)
- Pain of skin
60+:
- Blood pressure increased
- Fall
- Bacteraemia (presence of bacteria in the blood)
- Blood glucose increased
- Cervical vertebral fracture
- Confusional state
- Death
- Depression
- Diarrhoea
- Disease complication
What are the existing conditions these people have? *
- High Blood Pressure: 5 people, 27.78%
- Hyperkalemia (damage to or disease of the kidney): 3 people, 16.67%
- High Blood Cholesterol: 3 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
- Cardiac Disorder: 2 people, 11.11%
- Stress And Anxiety: 2 people, 11.11%
- Insomnia (sleeplessness): 2 people, 11.11%
- Diabetes: 2 people, 11.11%
- Chronic Kidney Disease: 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Gengraf and Multivitamin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gengraf (960 reports)
- Multivitamin (83,597 reports)
Browse all drug interactions of Gengraf and Multivitamin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gengraf:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Multivitamin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gengraf and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Multivitamin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Gengraf and Multivitamin, respectively), and Gengraf and Multivitamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lunesta cause Septic Shock? - 2 seconds ago
- Could Cymbalta cause Lung Consolidation? - 2 seconds ago
- Could Amphetamine cause Compartment Syndrome? - 4 seconds ago
- Could Ranitidine cause Lung Infection? - 7 seconds ago
- Could Ketalar cause Metabolic Acidosis? - 14 seconds ago
- Could Zoloft cause Laryngeal Oedema? - 17 seconds ago
- Drug interactions of Hydramine and Phosphatidyl Serine - 17 seconds ago
- Could Gemcitabine cause Lung Infection? - 20 seconds ago
- Drug interactions of Amoxicillin and Perjeta - 21 seconds ago
- Could Clopidogrel Bisulfate cause Haematemesis? - 22 seconds ago